文源 | 源媒汇作者 | 胡青木编辑 | 苏淮联邦制药,终于迎来了一场“及时雨”。2025年6月20日,联邦制药发布公告称,公司确认收到诺和诺德支付的UBT251三靶点减肥药预付款1.8亿美元。按当日汇率折算,这笔约合人民币12.93亿元的资金,相当于联邦制药2024年净利润的50%。截图来源于公司公告作为以原料药和胰岛素及抗生素制剂为核心的珠海传统药企,联邦制药近年来深陷转型阵痛:2024年受...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.